TREATMENT OF INTOXICATIONS WITH CONTINUOUS RENAL REPLACEMENT THERAPY - PowerPoint PPT Presentation

1 / 22
About This Presentation
Title:

TREATMENT OF INTOXICATIONS WITH CONTINUOUS RENAL REPLACEMENT THERAPY

Description:

CVVHD following HD for Lithium poisoning. HD started. CVVHD started. CT-190 ... lithium. methotrexate (p. brophy) Plasmapheresis / Exchange Blood Transfusions ... – PowerPoint PPT presentation

Number of Views:239
Avg rating:3.0/5.0
Slides: 23
Provided by: patbr6
Category:

less

Transcript and Presenter's Notes

Title: TREATMENT OF INTOXICATIONS WITH CONTINUOUS RENAL REPLACEMENT THERAPY


1
TREATMENT OF INTOXICATIONS WITH CONTINUOUS RENAL
REPLACEMENT THERAPY
  • Patrick D Brophy MD FRCPC
  • University of Michigan
  • June 23, 2000
  • 1st annual PCRRT, Orlando, FL

2
(p. brophy)
  • INTRODUCTION
  • 2.2 million reported poisonings (1998) 67 in
    pediatrics
  • Approximately 0.05 required extracorporeal
    elimination
  • Primary prevention strategies for acute
    ingestions have been designed and implemented
    (primarily with legislative effort) with a
    subsequent decrease in poisoning fatalities

3
(p. brophy)
  • Poison Management
  • DECONTAMINATION/TREATMENT OPTIONS FOR OVERDOSE
  • Standard Airway, Breathing and Circulatory
    measures take precedent
  • Oral Charcoal
  • Bowel Cleansing Regimens
  • Antidotes IV or PO when applicable
  • IV Hydration

4
(p. brophy)
  • Extracorporeal Methods
  • Peritoneal Dialysis
  • Hemodialysis
  • Hemofiltration
  • Charcoal hemoperfusion
  • Considerations
  • Volume of Distribution (Vd)/compartments
  • molecular size
  • protein/lipid binding
  • solubility

5
(p. brophy)
ELIMINATION
I N P U T
Distribution
Re-distribution
6
(p. brophy)
  • GENERAL PRINCIPLES
  • kinetics of drugs are based on therapeutic not
    toxic levels (therefore kinetics may change)
  • choice of extracorporeal modality is based on
    availability, expertise of people the
    properties of the intoxicant in general
  • Each Modality has drawbacks
  • It may be necessary to switch modalities during
    therapy (combined therapies inc endogenous
    excretion/detoxification methods)

7
(p. brophy)
  • INDICATIONS
  • gt48 hrs on vent
  • ARF
  • Impaired metabolism
  • high probability of significant
    morbidity/mortality
  • progressive clinical deterioration
  • INDICATIONS
  • severe intoxication with abnormal vital signs
  • complications of coma
  • prolonged coma
  • intoxication with an extractable drug

8
(p. brophy)
  • PERITONEAL DIALYSIS
  • 1st done in 1934 for 2 anuric patients after
    sublimate poisoning (Balzs et al Wien Klin Wschr
    193447851 )
  • Allows diffusion of toxins across peritoneal
    membrane from mesenteric capillaries into
    dialysis solution within the peritoneal cavity
  • limited use in poisoning (clears drugs with low
    Mwt., Small Vd, minimal protein binding those
    that are water soluble)
  • alcohols, NaCl intoxications, salicylates

9
(p. brophy)
  • HEMODIALYSIS
  • optimal drug characteristics for removal
  • relative molecular mass lt 500
  • water soluble
  • small Vd (lt 1 L/Kg)
  • minimal plasma protein binding
  • single compartment kinetics
  • low endogenous clearance (lt 4ml/Kg/min)
  • (Pond, SM - Med J Australia 1991 154 617-622)

10
(p. brophy)
  • Intoxicants amenable to Hemodialysis
  • vancomycin (high flux)
  • alcohols
  • diethylene glycol
  • methanol
  • lithium
  • salicylates

11
(p. brophy)
12
(p. brophy)
  • CHARCOAL HEMOPERFUSION
  • optimal drug characteristics for removal
  • Adsorbed by activated charcoal
  • small Vd (lt 1 L/Kg)
  • single compartment kinetics
  • protein binding minimal (can clear some highly
    protein bound molecules)
  • low endogenous clearance (lt 4ml/Kg/min)
  • (Pond, SM - Med J Australia 1991 154 617-622)

13
(p. brophy)
14
(p. brophy)
  • Intoxicants amenable to Charcoal Hemoperfusion
  • Carbamazepine
  • phenobarbital
  • phenytoin
  • theophylline
  • paraquat

15
(p. brophy)
  • HEMOFILTRATION
  • optimal drug characteristics for removal
  • relative molecular mass less than the cut-off of
    the filter fibres (usually lt 40,000)
  • small Vd (lt 1 L/Kg)
  • single compartment kinetics
  • low endogenous clearance (lt 4ml/Kg/min)
  • (Pond, SM - Med J Australia 1991 154 617-622)

16
(p. brophy)
  • Continuous Detoxification methods
  • CAVHF, CAVHD, CAVHP, CVVHF, CVVHD, CVVHP
  • Indicated in cases where removal of plasma toxin
    is then replaced by redistributed toxin from
    tissue
  • Can be combined with acute high flux HD

17
(p. brophy)
L i m E q / L
CVVHD following HD for Lithium poisoning
HD started
Li Therapeutic range 0.5-1.5 mEq/L
CVVHD started
CT-190 (HD) Multiflo-60 both patients BFR-pt 1
200 ml/min HD CVVHD -pt 2 325
ml/min HD 200 ml/min CVVHD PO4 Based
dialysate at 2L/1.73m2/hr
Hours
18
(p. brophy)
  • Intoxicants amenable to Hemofiltration
  • vancomycin
  • methanol
  • procainamide
  • hirudin
  • thallium
  • lithium
  • methotrexate

19
(p. brophy)
  • Plasmapheresis / Exchange Blood Transfusions
  • Plasmapheresis (Seyffart G. Trans Am Soc Artif
    Intern Organs 1982 28673)
  • role in intoxication not clearly established
  • most useful for highly protein bound agents
  • Exchange Blood Transfusions
  • Pediatric experience gt than adult
  • Methemoglobinemia
  • overall very limited role in poisoning

20
(p. brophy)
  • OTHER ISSUES
  • Optimal prescription
  • biocompatible filters - may increase protein
    adsorption
  • maximal blood flow rates (ie good access)
  • physiological solution (ARF vs non ARF)
  • ? Removal of antidote
  • counter-current D maximal removal of toxins

21
(p. brophy)
  • DIALYZE EARLY ! DIALYZE OFTEN !
  • PHYSIOLOGY ? ITS GOT NOTHING TO DO WITH
    PHYSIOLOGY ! HELL, THIS IS CHEMISTRY
  • T. Bunchman - 1999

22
(p. brophy)
  • ACKNOWLEDGEMENTS
  • TIMOTHY BUNCHMAN
  • DIANE HILFINGER
  • ANDREE GARDNER
  • JOHN GARDNER
  • THERESA MOTTES
  • TIM KUDELKA
  • LAURA DORSEY BETSY ADAMS
Write a Comment
User Comments (0)
About PowerShow.com